Cargando…
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net
Innovations are urgently required for clinical development of antibacterials against multidrug-resistant organisms. Therefore, a European, public-private working group (STAT-Net; part of Combatting Bacterial Resistance in Europe [COMBACTE]), has reviewed and tested several innovative trials designs...
Autores principales: | de Kraker, Marlieke E A, Sommer, Harriet, de Velde, Femke, Gravestock, Isaac, Weiss, Emmanuel, McAleenan, Alexandra, Nikolakopoulos, Stavros, Amit, Ohad, Ashton, Teri, Beyersmann, Jan, Held, Leonhard, Lovering, Andrew M, MacGowan, Alasdair P, Mouton, Johan W, Timsit, Jean-François, Wilson, David, Wolkewitz, Martin, Bettiol, Esther, Dane, Aaron, Harbarth, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260160/ https://www.ncbi.nlm.nih.gov/pubmed/30107400 http://dx.doi.org/10.1093/cid/ciy516 |
Ejemplares similares
-
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-Net
por: Timsit, Jean-François, et al.
Publicado: (2017) -
Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study
por: Gomila, Aina, et al.
Publicado: (2019) -
Estimands to quantify prolonged hospital stay associated with nosocomial infections
por: Wolkewitz, Martin, et al.
Publicado: (2019) -
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project
por: Pezzani, Maria Diletta, et al.
Publicado: (2020) -
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
por: de Kraker, Marlieke E. A., et al.
Publicado: (2016)